Clinical Trials Browser

INDUSTRY × Glioma × reolysin × Clear all

NCT00528684 2014-10-02

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Phase 1 Completed

Glioblastoma, Glioma